The University of Southampton
University of Southampton Institutional Repository

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)

Jones, William G., Fossa, Sophie D., Mead, Graham M., Roberts, J. Trevor, Sokal, Michael, Horwich, Alan and Stenning, Sally P. (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) Journal of Clinical Oncology, 23, (6), pp. 1200-1208. (doi:10.1200/JCO.2005.08.003).

Record type: Article

Abstract

PURPOSE: To assess the possibility of reducing radiotherapy doses without compromising efficacy in the management of patients with stage I seminoma.
PATIENTS AND METHODS: Patients were randomly assigned 20 Gy/10 fractions over 2 weeks or 30 Gy/15 fractions during 3 weeks after orchidectomy. They completed a symptom diary card during treatment and quality-of-life forms pre- and post-treatment. The trial was powered to exclude absolute differences in 2-year relapse rates of 3% to 4% ( = .05 [one sided]; 90% power).
RESULTS: From 1995 to 1998, 625 patients were randomly assigned to treatment. Four weeks after starting radiotherapy, significantly more patients receiving 30 Gy reported moderate or severe lethargy (20% v 5%) and an inability to carry out their normal work (46% v 28%). However, by 12 weeks, levels in both groups were similar. With a median follow-up of 61 months, 10 and 11 relapses, respectively, have been reported in the 30- and 20-Gy groups (hazard ratio, 1.11; 90% CI, 0.54 to 2.28). The absolute difference in 2-year relapse rates is 0.7%; the lower 90% confidence limit is 2.9%. Only one patient has died from seminoma (allocated to the 20-Gy treatment group).
CONCLUSION: Treatment with 20 Gy in 10 fractions is unlikely to produce relapse rates more than 3% higher than for standard 30 Gy radiation therapy, and data on an additional 469 patients randomly assigned in a subsequent trial support and strengthen these results. Reductions in morbidity enable patients to return to work more rapidly. Prolonged follow-up is required before any inference can be made about any impact of allocated treatment on new primary cancer diagnoses.

PDF 40712.pdf - Version of Record
Restricted to Repository staff only
Download (1MB)

More information

Published date: 2005

Identifiers

Local EPrints ID: 40712
URI: http://eprints.soton.ac.uk/id/eprint/40712
ISSN: 1527-7755
PURE UUID: 3811bbb6-8acf-4bdd-b721-0939c658ebdb

Catalogue record

Date deposited: 07 Jul 2006
Last modified: 17 Jul 2017 15:33

Export record

Altmetrics

Contributors

Author: William G. Jones
Author: Sophie D. Fossa
Author: Graham M. Mead
Author: J. Trevor Roberts
Author: Michael Sokal
Author: Alan Horwich
Author: Sally P. Stenning

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×